US Stock MarketDetailed Quotes
ELTP ELITE PHARMACEUTICALS INC
- 0.585
- +0.002+0.34%
15min DelayClose Nov 29 13:00 ET
624.94MMarket Cap-58500P/E (TTM)
0.595High0.567Low664.67KVolume0.583Open0.583Pre Close385.04KTurnover0.08%Turnover Ratio29.25P/E (Static)1.07BShares0.75552wk High13.30P/B486.78MFloat Cap0.12152wk Low--Dividend TTM832.10MShs Float0.755Historical High--Div YieldTTM4.84%Amplitude0.093Historical Low0.579Avg Price1Lot Size
About ELITE PHARMACEUTICALS INC Company
Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications and New Drug Applications segments. The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
Company Profile
SymbolELTP
Company NameELITE PHARMACEUTICALS INC
Founded1997
MarketPink Market
Employees64
Fiscal Year Ends03-31
Address165 Ludlow Avenue
CityNorthvale
ProvinceNew Jersey
CountryUnited States of America
Zip Code07647
Phone1-201-750-2646
Websitehttp://www.elitepharma.com
Company Executives
- Name
- Position
- Salary
- Nasrat Hakim
- President, Chief Executive Officer and Director
- --
- Carter J. Ward
- Chief Financial Officer, Secretary and Treasurer
- --
- Douglas Plassche
- Executive Vice President of Operations
- --
- Jeffrey Whitnell
- Director
- --
- Davis Caskey
- Director
- --
- Barry Dash, Ph. D
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data